CNBC   |  April 17, 2013

R&D For Your Portfolio: 3 Stocks in 3 Sectors

Mark Lehmann, JMP Securities president, provides investment strategies that include a biotech company with a promising drug to fight a rare form of Leukemia.

Share This:

Sorry, we do not have a transcript available for this video at this time.